• Nenhum resultado encontrado

Prostate cancer - Diagnosis

Editor’s Pick: PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy

Editor’s Pick: PSMA-Specific Ligands in Prostate Cancer Diagnosis and Therapy

... of prostate cancer. It is overexpressed in almost all prostate cancers, and the expression level increases with prostate cancer ...for prostate cancer diagnosis and ...

8

Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification.

Susceptibility weighted imaging: a new tool in the diagnosis of prostate cancer and detection of prostatic calcification.

... the diagnosis of prostate cancer in the prostate peripheral zone but not ...the prostate peripheral ...the prostate, up to 30% of prostate cancers occur within the central ...

7

Prostate-Specific Antigen testing in men between 40 and 70 years in Brazil: database from a check-up program

Prostate-Specific Antigen testing in men between 40 and 70 years in Brazil: database from a check-up program

... of prostate cancer; however, some cases will be ...of cancer but at the cost of labeling more men as potentially having the ...a prostate cancer diagnosis in the number of men ...

8

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Finasteride concentrations and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

... (DRE), prostate specific antigen (PSA) level of 3 ng/mL or below, and no history of prostate cancer or other clinically significant co- morbid conditions that would have precluded successful ...

13

Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer

Differential expression of the KLK2 and KLK3 genes in peripheral blood and tissues of patients with prostate cancer

... in prostate tissue from 42 prostate cancer patients, 33 of whom were also assessed for pe- ripheral blood KLK2 expression by qualitative semi-nested ...between prostate cancer patients ...

7

Production and Purification of pre-miRNA-149 with potential application in diagnosis of prostate cancer

Production and Purification of pre-miRNA-149 with potential application in diagnosis of prostate cancer

... Finally, for the purification process three different supports (naphthalene amine; L-tyrosine and L-lysine) are used in the affinity chromatography to purify the pre-miRNA-149[r] ...

66

en 0100 3984 rb 47 05 000V

en 0100 3984 rb 47 05 000V

... the prostate, emphasizing the essential requirements that should be met by each functional technique, diffusion-weighted imaging, dynamic contrast-enhancement, and proton spectroscopy proto- cols, as well as by ...

2

Radiol Bras  vol.46 número2

Radiol Bras vol.46 número2

... tant to note that, despite the continuous progress of imaging methods, particularly magnetic resonance imaging, searching for a correct diagnosis of prostate cancer, transrectal ultrasound (US) ...

1

Mobile application-based Seoul National University Prostate Cancer Risk Calculator: development, validation, and comparative analysis with two Western risk calculators in Korean men.

Mobile application-based Seoul National University Prostate Cancer Risk Calculator: development, validation, and comparative analysis with two Western risk calculators in Korean men.

... Many predictive models to diagnosis PC at initial biopsy have been made mostly with Western data [6,8,11,12]. Even though these predictive tools have been validated in the Western population, their extrapolation ...

7

Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.

Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis.

... Prostate cancer (PCa) remains as one of the most common cause of cancer related death among men in the ...used prostate specific antigen (PSA) screening is limited by low ...in prostate ...

8

Espectroscopia por ressonância magnética no diagnóstico do câncer de próstata: experiência inicial

Espectroscopia por ressonância magnética no diagnóstico do câncer de próstata: experiência inicial

... for cancer and high specific-prostatic antigen levels (group A), and patients with cancer confirmed by biopsy (group ...known cancer extent (group B) was based on magnetic resonance imaging and MRSI ...

6

Optimal use of prostate specific antigen for prostate cancer screening

Optimal use of prostate specific antigen for prostate cancer screening

... of cancer diagnosis during the intervening ...of prostate cancer at 15 years follow-up 23 ...advanced cancer during the last follow-up (RR: ...

3

Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.

Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.

... of cancer was based on individuals’ responses to the questions asking ‘‘List any significant past medical illness or health problems’’ and ‘‘List any previous injuries and/or ...a diagnosis of cancer ...

7

Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ngmL

Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ngmL

... of prostate- -specific antigen (PSA) has been used in clinical practice since 1988, and has become the most va- luable tumor marker widely used in screening for prostate ...benign prostate ...

8

Prevention and early diagnosis save men’s lives in the north of Minas Gerais

Prevention and early diagnosis save men’s lives in the north of Minas Gerais

... early diagnosis of cancer in the municipal of Montes Claros, Minas Gerais and show the changes ...confirmed prostate cancer. Conclusion: The Prevention and Early Diagnosis of ...

8

Cancer stem cells in prostate cancer: implications for targeted therapy

Cancer stem cells in prostate cancer: implications for targeted therapy

... regarding PCa and also for treatment resistance and disease progression once clinical cure is achieved. Therapies target- ing CSCs might therefore lead to more effective cancer treat- ments, divergent from a ...

12

Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.

Morphological differences between circulating tumor cells from prostate cancer patients and cultured prostate cancer cells.

... Circulating tumor cells (CTCs) have been implicated as potential seeds of cancer metastasis and are therefore of great importance in research, disease management, and drug develop- ment [1–3]. Established methods ...

7

Prostate cancer – Therapy with radium-223

Prostate cancer – Therapy with radium-223

... resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPC ...castration-resistant ...

5

STRATEGIES FOR THE PREVENTION OF PROSTATE CANCER

STRATEGIES FOR THE PREVENTION OF PROSTATE CANCER

... for prostate cancer are, surely, the most important step of this treatment, because it is at this early stage of the disease that it has the opportunity to offer men a, effective and cheaper treatment ...

13

Int. braz j urol.  vol.36 número6

Int. braz j urol. vol.36 número6

... The timing of cystectomy in T1 bladder cancer is a matter of debate since years. Here, the authors from a tertiary referral center present their series of 523 patients and analyze variables which may help with the ...

3

Show all 8201 documents...

temas relacionados